Resultats de la cerca - Boris Rodenko
- Mostrar 1 - 7 resultats de 7
-
1
Ubiquitin‐Based Probes Prepared by Total Synthesis To Profile the Activity of Deubiquitinating Enzymes per Annemieke de Jong, Remco Merkx, Ilana Berlin, Boris Rodenko, Ruud H. Wijdeven, Dris El Atmioui, Zeliha Yalçin, Craig Robson, Jacques Neefjes, Huib Ovaa
Publicat 2012Artigo -
2
Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules per Celia R. Berkers, Annemieke de Jong, Karianne Schuurman, Carsten Linnemann, Hugo D. Meiring, Lennert Janssen, Jacques Neefjes, Ton N. Schumacher, Boris Rodenko, Huib Ovaa
Publicat 2015Artigo -
3
Essential roles for deubiquitination in Leishmania life cycle progression per Andreas Damianou, Rebecca J. Burge, Carolina Moura Costa Catta‐Preta, Vincent Geoghegan, Y. Romina Nievas, Katherine Newling, Elaine Brown, Richard Burchmore, Boris Rodenko, Jeremy C. Mottram
Publicat 2020Artigo -
4
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7 per Arne Bakker, Rieuwert Hoppes, Carsten Linnemann, Mireille Toebes, Boris Rodenko, Celia R. Berkers, Sine Reker Hadrup, Wim J.E. van Esch, Mirjam H.M. Heemskerk, Huib Ovaa, Ton N. Schumacher
Publicat 2008Artigo -
5
Proteasome Activation by Small Molecules per Yves Leestemaker, Annemieke de Jong, Katharina F. Witting, Renske Penning, Karianne Schuurman, Boris Rodenko, Esther A. Zaal, Bert van de Kooij, Stefan Laufer, Albert J. R. Heck, Jannie Borst, Wiep Scheper, Celia R. Berkers, Huib Ovaa
Publicat 2017Artigo -
6
Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2–Restricted T Cell Epitopes per Rieuwert Hoppes, Rimke Oostvogels, Jolien J. Luimstra, Kim Wals, Mireille Toebes, Laura Bies, Reggy Ekkebus, Pramila Rijal, Patrick H. N. Celie, Julie H. Huang, Maarten E. Emmelot, Robbert M. Spaapen, Henk M. Lokhorst, Ton N. Schumacher, Tuna Mutis, Boris Rodenko, Huib Ovaa
Publicat 2014Artigo -
7
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis per Christophe Desmet, Tristan Gallenne, Alexandre Prieur, Fabien Reyal, Nils L. Visser, Ben S. Wittner, Marjon A. Smit, Thomas R. Geiger, Jamila Laoukili, Sedef Iskit, Boris Rodenko, Wilbert Zwart, Bastiaan Evers, Hugo M. Horlings, Abderrahrim Ajouaou, John Zevenhoven, M. van Vliet, Sridhar Ramaswamy, Lodewyk F.A. Wessels, Daniel S. Peeper
Publicat 2013Artigo
Eines de cerca:
Matèries relacionades
Biology
Biochemistry
Gene
Cell biology
Chemistry
Genetics
Computational biology
Computer science
RNA
Ubiquitin
Antigen
Deubiquitinating enzyme
Enzyme
Epitope
Human leukocyte antigen
MHC class I
Major histocompatibility complex
Medicine
Peptide
Proteasome
RNA splicing
Small molecule
Alternative splicing
Amastigote
Antigen presentation
Antigen processing
Artificial intelligence
Biotinylation
Breast cancer
CD8